Currencies

Currency Converter

* From and To currency are the same
* Amount Entered Is Invalid

Overview


Currency Table

Currency Last Day High Day Low % Change Bid Ask
GBP/USD 1.6085 1.6093 1.6015 +0.36% 1.6085 1.6088
GBP/EUR 1.2631 1.2640 1.2604 +0.17% 1.2631 1.2635
USD/EUR 0.78933 0.79158 0.78846 -0.19% 0.78933 0.78927
GBP/JPY 172.69 172.99 172.24 +0.42% 172.69 172.73
GBP/CHF 1.5233 1.5256 1.5201 +0.03% 1.5233 1.5242
GBP/AUD 1.8392 1.8418 1.8324 -0.06% 1.8392 1.8399

Sterling up on UK GDP, eyes first weekly rise in four

LONDON, Oct 24 - Sterling rose against the dollar on Friday after figures showed the UK economy met expectations and grew at a healthy pace, providing a relief for those worried that weakness overseas could be a drag on activity.

  • Europe
  • U.S.
  • Asia
  • Sectors
Stock Search
FTSE 100 6,388.73 -30.42 -0.47%
DAX 8,815.56 +97.80 +1.12%
CAC 40 4,128.90 -28.78 -0.69%
TR Europe 155.32 +4.06 +2.68%
GBP/USD 1.6085 +0.36%
GBP/EUR 1.2631 +0.17%
EUR/USD 1.2669 +0.19%
Gold 1,236.80 -1.50 -0.12%
Oil 82.70 -0.05 -0.06%
Corn 344.50 -3.50 -1.01%

Fitch Affirms Spain at 'BBB+'; Outlook Stable

(The following statement was released by the rating agency) LONDON, October 24 (Fitch) Fitch Ratings, London, Fitch Ratings has affirmed Spain's Long-term foreign and local currency Issuer Default Ratings (IDRs) at 'BBB+'. The issue ratings on Spain's senior unsecured foreign and local currency bonds have also been affirmed at 'BBB+'. The Outlooks on the Long-term IDRs are Stable. The Country Ceiling has been affirmed at 'AA+' and the Short-term foreign currency IDR at 'F2'. KEY RATING DRIV

GLOBAL MARKETS-Shares rise, set for strongest week since July 2013

* Microsoft, Procter & Gamble results lift U.S. shares * Ebola scare limits U.S. gains, weighs on Europe stocks * U.S. Treasuries prices edge higher on Ebola fear * Euro rises ahead of European bank stress test results (Adds close of European bond, stock markets) By Sam Forgione NEW YORK, Oct 24 - Global equity markets rose on Friday as gains in Microsoft and Procter & Gamble buoyed U.S. shares, even as news that a New York City doctor tested positive for the Ebol